Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer
Radiation Oncology Journal. 2015;33(2):89 
127 Outcome of CyberKnife radiosurgery for early stage lung cancer
Lung Cancer. 2016;91:S46
179 Early outcome in patients with early stage non-small cell lung cancer treated with stereotactic body radiotherapy (Cyberknife): Mount Vernon Cancer Centre experience
Lung Cancer. 2013;79:S61-S62
Clinical outcome of cyberknife radiosurgery in brain metastases of non-small cell lung cancer: A single institutional experience
Annals of Oncology. 2017;28:ii54
Clinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancers
Lung Cancer. 1994;11:182
Adjuvant Systemic Therapies in Early-Stage Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2003;5:S29-S35
Benefit of dosimetry distribution for patients with brain metastases from non-small cell lung cancer by Cyberknife Stereotactic radiosurgery (SRS) system
. 2020;
Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
Medical Oncology. 2015;32(3):
Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by Cyberknife Stereotactic radiosurgery (SRS) system
. 2020;
Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by Cyberknife Stereotactic radiosurgery (SRS) system
. 2020;